Home › Funds › MYDA Advisors LLC › BNTC

MYDA Advisors LLC position in BNTC

BENITEC BIOPHARMA INC · Health Care

MYDA Advisors LLC reported holding 250,000 shares of BNTC (BENITEC BIOPHARMA INC) in its Q2 2026 13F filing — a position valued at US$3.3M, representing 0.70% of its reported portfolio and ranking #42 among its reported holdings. MYDA Advisors LLC has disclosed BNTC holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)250.00K sh
Reported value held$3.35M
Portfolio Weight0.70%
First reportedQ4 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How MYDA Advisors LLC's BNTC position evolved

MYDA Advisors LLC first disclosed a stake in BNTC in Q4 2024 at 50,000 shares (US$632K). The position peaked in Q2 2026 at 250,000 shares, worth US$3.3M. Across 7 filings, MYDA Advisors LLC increased the stake 5 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 250,000 shares valued at US$3.3M — an increase of 25,000 shares quarter over quarter.. Notable position changes include a 221% increase in Q4 2025 (shares fell 21% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 50.00K $631.50K New
Q1 2025 52.00K $676.52K Add
Q2 2025 62.12K $726.76K Add
Q3 2025 70.00K $982.10K Add
Q4 2025 225.00K $3.03M Add
Q1 2026 225.00K $2.40M Hold
Q2 2026 250.00K $3.35M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BNTC and 13F data

BNTC (BENITEC BIOPHARMA INC) is a Health Care company. 56 other funds we track also report a position in BNTC — the largest reported positions include MONTANOVA CAPITAL, LLC (US$154.5M), Nantahala Capital Management, LLC (US$19.9M), Simplify Asset Management Inc. (US$13.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BNTC

All BNTC fund holders →

FAQ

How long has MYDA Advisors LLC held BNTC?

MYDA Advisors LLC has disclosed BNTC holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is MYDA Advisors LLC's current position in BNTC?

As of Q2 2026, MYDA Advisors LLC holds 250.00K shares of BNTC (BENITEC BIOPHARMA INC), valued at $3.35M, representing 0.70% of its reported portfolio and ranking #42.

Has MYDA Advisors LLC been buying or selling BNTC?

In the latest 13F filing (Q2 2026), MYDA Advisors LLC increased its position in BNTC. The position peaked in Q2 2026 at 250.00K shares.

Which other funds hold BNTC?

Other major institutional holders of BNTC include MONTANOVA CAPITAL, LLC, Nantahala Capital Management, LLC, Simplify Asset Management Inc., among 56 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.